Delivery Order SPE2DB20D3505-SPE2DB24FU8C4
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $1,652.35. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 8, 2024 and is structured as a firm fixed-price delivery order. The contract is not designated as a set-aside....
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,805.87 firm fixed price delivery order contract has a completion date of May 2, 2024 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999...
The federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen 2 ml, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a total ceiling value of $22,336.77 and is a firm fixed-price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,055.64, is a delivery order with a firm fixed price pricing type. It has an ultimate completion date of July 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $80,235.95. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed-price pricing type, and an ultimate completion date of March 4, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen in a 2 ml size. The contract, awarded by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 28, 2025. The award has a ceiling value of $17,149.48 and is a firm fixed-price delivery order contract with a completion date of January 29, 2025. The contract does not have a set-aside designation. AmerisourceBergen holds a significant...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,441.69 and a completion date of December 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, with a ceiling value of $15,972.40. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of July 15, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which provides a range of medical commodities to military treatment programs and facilities worldwide. The contract has a ceiling value of $6,130.34 and a completion date of August 30, 2024....
This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, with a ceiling value of $15,415.79. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency, a defense agency. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of May 28, 2025 and was awarded on May 27, 2025. The award is not a...